Momenta Pharmaceuticals, Inc.
MNTA
MNTA was delisted on the 30th of September, 2020.
158 hedge funds and large institutions have $1.05B invested in Momenta Pharmaceuticals, Inc. in 2018 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 72 increasing their positions, 38 reducing their positions, and 34 closing their positions.
175% more call options, than puts
Call options by funds: $771K | Put options by funds: $280K
89% more repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 38
0.56% less ownership
Funds ownership: 97.5% → 96.94% (-0.56%)
1% less funds holding
Funds holding: 159 → 158 (-1)
3% less first-time investments, than exits
New positions opened: 33 | Existing positions closed: 34
48% less capital invested
Capital invested by funds: $2.01B → $1.05B (-$954M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$49.5M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$42.1M |
| 3 |
PA
Perceptive Advisors
New York
|
+$39M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$36.4M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$29.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
-$43.2M |
| 2 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
-$28.5M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$20.8M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$12.6M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$10.4M |
MNTA Hedge Fund Activity: Q4 2018 in Review
158 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Momenta Pharmaceuticals, Inc. (MNTA) for Q4 2018, worth a combined $1.05B — down 48% from $2.01B a quarter earlier.
Sellers outnumbered buyers: 34 funds closed out of MNTA and 33 opened new positions — a net loss of 1 holder — while 38 trimmed existing stakes and 72 added.
The largest buyer was Wellington Management Group, adding an estimated $49.5M. The largest seller was Janus Henderson Group, exiting entirely with an estimated $43.2M sold.
- 158 institutional investors held Momenta Pharmaceuticals, Inc. (MNTA) as of Q4 2018, down from 159 in Q3 2018.
- Funds reported $1.05B of Momenta Pharmaceuticals, Inc. stock for Q4 2018, down 48% quarter-over-quarter.
- 33 funds opened new Momenta Pharmaceuticals, Inc. positions in Q4 2018 and 34 closed out, a net change of -1 holder.
- The largest Momenta Pharmaceuticals, Inc. buyer in Q4 2018 was Wellington Management Group, an estimated $49.5M added.
- The largest Momenta Pharmaceuticals, Inc. seller in Q4 2018 was Janus Henderson Group, an estimated $43.2M sold.
Based on aggregated 13F filings for Q4 2018.